IHM
SRNE

Iguana Healthcare Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Iguana Healthcare Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-130,000
Closed -$878K – 83
2014
Q2 		$878K Buy
130,000
+80,000
+160% +$603K 0.41% 58
2014
Q1 		$641K Buy
+50,000
New +$553K 0.3% 66

Other funds holding SRNE

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
B
Baird Milwaukee, Wisconsin $9.78B AUM 11.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Iguana Healthcare Management's SRNE Position: Q3 2014 in Review

Iguana Healthcare Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2014, closing a stake of 130,000 shares — an estimated $878K sold.

Iguana Healthcare Management first reported a position in SRNE in Q1 2014 and held it in 2 quarters. The position peaked at $878K in Q2 2014. 33 funds tracked by Wall St. Rank hold SRNE as of Q3 2014.

  • Iguana Healthcare Management reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2014 after selling out during the quarter.
  • Iguana Healthcare Management sold 130,000 Sorrento Therapeutics, Inc. shares in Q3 2014, an estimated $878K.
  • Iguana Healthcare Management first reported a position in Sorrento Therapeutics, Inc. in Q1 2014 and held it in 2 quarters.
  • Iguana Healthcare Management's Sorrento Therapeutics, Inc. position peaked at $878K in Q2 2014.
  • 33 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2014.

Based on Iguana Healthcare Management's 13F filing for Q3 2014, filed 14 Nov 2014.